Thyroid function in Klinefelter syndrome: a multicentre study from KING group.


Journal

Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 19 12 2018
accepted: 20 03 2019
pubmed: 27 3 2019
medline: 7 2 2020
entrez: 27 3 2019
Statut: ppublish

Résumé

The prevalence and the etiopathogenesis of thyroid dysfunctions in Klinefelter syndrome (KS) are still unclear. The primary aim of this study was to evaluate the pathogenetic role of hypogonadism in the thyroid disorders described in KS, with the scope to distinguish between patients with KS and hypogonadism due to other causes (Kallmann syndrome, idiopathic hypogonadotropic hypogonadism, iatrogenic hypogonadism and acquired hypogonadotropic hypogonadism after surgical removal of pituitary adenomas) called non-KS. Therefore, we evaluated thyroid function in KS and in non-KS hypogonadal patients. This is a case-control multicentre study from KING group: Endocrinology clinics in university-affiliated medical centres. One hundred and seventy four KS, and sixty-two non-KS hypogonadal men were enrolled. The primary outcome was the prevalence of thyroid diseases in KS and in non-KS. Changes in hormonal parameters were evaluated. Exclusion criterion was secondary hypothyroidism. Analyses were performed using Student's t test. Mann-Whitney test and Chi-square test. FT4 was significantly lower in KS vs non-KS. KS and non-KS presented similar TSH and testosterone levels. Hashimoto's thyroiditis (HT) was diagnosed in 7% of KS. Five KS developed hypothyroidism. The ratio FT3/FT4 was similar in both groups. TSH index was 1.9 in KS and 2.3 in non-KS. Adjustment for differences in age, sample size and concomitant disease in multivariate models did not alter the results. We demonstrated in KS no etiopathogenic link to hypogonadism or change in the set point of thyrotrophic control in the altered FT4 production. The prevalence of HT in KS was similar to normal male population, showing absence of increased risk of HT associated with the XXY karyotype.

Identifiants

pubmed: 30912057
doi: 10.1007/s40618-019-01037-2
pii: 10.1007/s40618-019-01037-2
doi:

Substances chimiques

Thyroid Hormones 0
Thyrotropin 9002-71-5

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1199-1204

Investigateurs

Antonio Aversa (A)
Giancarlo Balercia (G)
Marco Bonomi (M)
Aldo Calogero (A)
Giovanni Corona (G)
Francesco Giorgino (F)
Andrea Fabbri (A)
Alberto Ferlin (A)
Emanuele Ferrante (E)
Felice Francavilla (F)
Vito Giagulli (V)
Emmanuele Jannini (E)
Fabio Lanfranco (F)
Mario Maggi (M)
Daniela Pasquali (D)
Rosario Pivonello (R)
Alessandro Pizzocaro (A)
Antonio Radicioni (A)
Vincenzo Rochira (V)
Linda Vignozzi (L)
Marco Barchi (M)
Biagio Cangiano (B)
Rosita A Condorelli (RA)
Giuliana Cordeschi (G)
Settimio D'Andrea (S)
Antonella Di Mambro (AD)
Carlo Foresta (C)
Sandro Francavilla (S)
Andrea Garolla (A)
Lara Giovannini (L)
Antonio R M Granata (ARM)
Sandro La Vignera (S)
Giovanna Motta (G)
Luciano Negri (L)
Fiore Pelliccione (F)
Luca Persani (L)
Ciro Salzano (C)
Daniele Santi (D)
Riccardo Selice (R)
Manuela Simoni (M)
Carla Tatone (C)
Giacomo Tirabassi (G)
Alberto Stefano Tresoldi (AS)
Enzo Vicari (E)

Références

J Clin Endocrinol Metab. 1999 Feb;84(2):561-6
pubmed: 10022416
Thyroid. 2004;14 Suppl 1:S17-25
pubmed: 15142373
Endocr Rev. 2004 Oct;25(5):722-46
pubmed: 15466939
J Clin Endocrinol Metab. 2005 Nov;90(11):5949-53
pubmed: 16105963
Clin Endocrinol (Oxf). 2009 Oct;71(4):529-34
pubmed: 19226261
J Clin Endocrinol Metab. 2009 Jul;94(7):2478-81
pubmed: 19401367
Mol Hum Reprod. 2010 Jun;16(6):418-24
pubmed: 20348547
Endocrine. 2012 Oct;42(2):252-65
pubmed: 22644837
Curr Genomics. 2011 Dec;12(8):576-88
pubmed: 22654557
Int J Cardiol. 2013 Sep 30;168(2):754-9
pubmed: 23092857
J Clin Endocrinol Metab. 2013 Jan;98(1):20-30
pubmed: 23118429
Gen Comp Endocrinol. 2014 Jul 1;203:69-85
pubmed: 24685768
Thyroid. 2014 Dec;24(12):1670-751
pubmed: 25266247
Autoimmunity. 2015 Mar;48(2):125-8
pubmed: 25295757
Andrology. 2015 Sep;3(5):876-81
pubmed: 26216452
Eur J Endocrinol. 2016 Jul;175(1):R27-40
pubmed: 26850445
Thyroid. 2016 Oct;26(10):1343-1421
pubmed: 27521067
J Endocrinol Invest. 2017 Feb;40(2):123-134
pubmed: 27644703
Endocrine. 2017 Feb;55(2):513-518
pubmed: 27726092
J Endocrinol Invest. 2017 Jul;40(7):705-712
pubmed: 28258556
Hum Mol Genet. 2017 Apr 1;26(7):1219-1229
pubmed: 28369266
Clin Endocrinol (Oxf). 2017 Jul;87(1):87-96
pubmed: 28374508
Mol Cell Endocrinol. 2018 May 15;467:49-59
pubmed: 29175529
Metabolism. 2018 Sep;86:135-144
pubmed: 29382506
Endocrine. 2018 Aug;61(2):194-203
pubmed: 29572708
Am J Med. 1986 Jun;80(6):1055-9
pubmed: 3088995
Acta Endocrinol (Copenh). 1977 Jan;84(1):72-9
pubmed: 401552
Lancet. 1967 Mar 25;1(7491):648-51
pubmed: 4163925

Auteurs

G Balercia (G)

Division of Endocrinology, Department of Clinical and Molecular Sciences, Umberto I Hospital, Polytechnic University of Marche, Ancona, Italy.

M Bonomi (M)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Division of Endocrine and Metabolic Diseases, Lab of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Milano, Italy.

V A Giagulli (VA)

Outpatient Clinic for Endocrinology and Metabolic Diseases, Conversano Hospital, Conversano, Bari, Italy.

F Lanfranco (F)

Division of Endocrinology, Diabetology, and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.

V Rochira (V)

Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria Di Modena, Ospedale Civile Di Baggiovara, Modena, Italy.

A Giambersio (A)

Healt Center "Maria Teresa Di Calcutta, Potenza, Italy.

G Accardo (G)

Department of Advanced Medical And Surgical Sciences, University of Campania "Luigi Vanvitelli", 80138, Naples, Italy.

D Esposito (D)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

S Allasia (S)

Division of Endocrinology, Diabetology, and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.

B Cangiano (B)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Division of Endocrine and Metabolic Diseases, Lab of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Milano, Italy.

S De Vincentis (S)

Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria Di Modena, Ospedale Civile Di Baggiovara, Modena, Italy.

R A Condorelli (RA)

Department of Clinical and Experimental Medicine, University of Catania, Policlinico "G. Rodolico", Catania, Italy.

A Calogero (A)

Department of Clinical and Experimental Medicine, University of Catania, Policlinico "G. Rodolico", Catania, Italy.

D Pasquali (D)

Department of Advanced Medical And Surgical Sciences, University of Campania "Luigi Vanvitelli", 80138, Naples, Italy. daniela.pasquali@unicampania.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH